Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05551091 · ClinicalTrials.gov registry record · NA

Glycomacropeptide and Women's Health

A NA study of Obesity, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT05551091 is a NA study of Obesity that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 13 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05551091, a NA study of Obesity, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

This is a study about how a dietary supplement containing a whey protein affects hormones controlling hunger and satiety (leptin and ghrelin) in postmenopausal women with a body mass index between 28 and 35 kg/m2. Participants can expect to be in study for 4 weeks.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT glycomacropeptide (GMP)

Study Locations (1)

Wisconsin

  • University of Wisconsin-Madison - Madison

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2019-04-09
Est. Completion 2022-07-05
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05551091

The ClinicalTrials.gov registry entry for NCT05551091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which glycomacropeptide (GMP) is the first listed.

NCT05551091 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05551091 about?

NCT05551091 is a clinical study titled "Glycomacropeptide and Women's Health". This is a study about how a dietary supplement containing a whey protein affects hormones controlling hunger and satiety (leptin and ghrelin) in postmenopausal women with a body mass index between 28 and 35 kg/m2. Participants can expect to be in study for 4 weeks.

What is the current status of trial NCT05551091?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2019-04-09. Estimated completion is 2022-07-05.

What conditions does trial NCT05551091 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT05551091?

The interventions under investigation include: glycomacropeptide (GMP) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05551091?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05551091 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.